The Latest Breaking News from Wall Street

Another leg higher in Treasury bond yields is muting stock gains heading into a busy earnings session on Wall Street.

Tesla stock is surging today after it crushed earnings estimates in Q3 of 2024 and provided an optimistic outlook for 2025. Wall Street hasn't been this excited since the company reported its first profitable quarter.

Wall Street remains optimistic about these strong semiconductor players, expecting more than 21% upside.

Inflation pressures are easing, but the pace is painstakingly slow.

Wall Street is looking to consolidate its recent rebound with a muted July inflation report.

With Tesla lagging behind the broader market, Wall Street analysts remain cautious about the stock’s prospects.

Wall Street expects both of these growth stocks to soar over 18% to 43%, but one of them is the better long-term buy right now.

This growth stock has tumbled in recent months, but analysts are forecasting more than 100% upside, based on Wall Street's mean price target.

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….